LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_012433.4:c.2098A>G
SF3B1
· NP_036565.2:p.(Lys700Glu)
· NM_012433.4
GRCh37: chr2:198266834 T>C
·
GRCh38: chr2:197402110 T>C
Gene:
SF3B1
Transcript:
NM_012433.4
Final call
Likely Pathogenic
PS3 strong
PM1 moderate
PM2 supporting
Variant details
Gene
SF3B1
Transcript
NM_012433.4
Protein
NP_036565.2:p.(Lys700Glu)
gnomAD AF
4.4885262048887535e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Likely Pathogenic: PS3 strong from variant-specific studies showing aberrant splicing and partial SUGP1 rescue.
2
Likely Pathogenic: PM1 moderate because K700E is a recurrent statistically significant SF3B1 hotspot.
3
Likely Pathogenic: PM2 supporting because gnomAD frequency is below 0.0001 with zero homozygotes.
Final determination:
Under the generic ACMG/AMP 2015 fallback, 1 strong pathogenic criterion plus 1 moderate pathogenic criterion plus 1 supporting pathogenic criterion supports Likely Pathogenic.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: K700E is a recurrent somatic hotspot, but no validated previously established pathogenic comparator is supplied for PS1. |
clinvar
PMID:25424858
cosmic
|
| PS2 | Not assessed | Not assessed: no documented maternity and paternity confirmation or family-history data establish a de novo occurrence. |
|
| PS3 | Met | Met, strong: K700E caused aberrant 3' splice-site usage in engineered and endogenous models, with partial rescue by SUGP1 overexpression. |
PMID:27818134
PMID:31474574
|
| PS4 | Not assessed | Not assessed: gnomAD v4.1 gives 72/1,604,090 control alleles, but no affected-case count exists to calculate the required OR/RR >5.0 and 95% CI excluding 1.0. |
gnomad_v4
PMID:25424858
|
| PM1 | Met | Met: K700E is at a statistically significant recurrent hotspot, with COSMIC reporting 811 occurrences and a study identifying codon 700 as a recurrent hotspot. |
hotspots
cosmic
PMID:25424858
|
| PM2 | Met | Met at supporting strength: gnomAD AF is 4.49e-05 in v4.1, below the <=0.0001 PM2 threshold, with zero homozygotes. |
gnomad_v2
gnomad_v4
|
| PM3 | Not assessed | Not assessed: no affected-proband observation or parental testing demonstrates this variant in trans with a pathogenic allele for a recessive disorder. |
PMID:27818134
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: no different pathogenic missense comparator at Lys700 is documented, while the reported K700E observations are the same amino-acid change. |
pm5_candidates
PMID:25424858
cosmic
|
| PM6 | Not assessed | Not assessed: no case-level evidence shows an assumed de novo variant without maternity and paternity confirmation. |
|
| PP1 | Not assessed | Not assessed: no affected relatives or informative meioses are documented to evaluate co-segregation. |
|
| PP2 | Not assessed | Not assessed: gene-wide benign missense depletion and a qualifying common missense disease mechanism are not both demonstrated by the supplied evidence. |
gnomad_v4
PMID:27818134
PMID:31474574
|
| PP3 | Not met | Not met: REVEL 0.619 is below the generic supporting PP3 threshold of 0.644 for this missense variant. |
revel
|
| PP4 | Not assessed | Not assessed: the available records provide no patient phenotype or family history that is highly specific for a single-gene disease. |
|
| PP5 | Not met | Not met: no exact-variant ClinVar expert-panel Pathogenic/Likely pathogenic classification is present; available submissions are non-expert and conflicting. |
clinvar
|
| BA1 | Not met | Not met: gnomAD maximum observed frequency is 2.97e-04, far below the 0.05 BA1 threshold. |
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: highest reported gnomAD ancestry frequency is 2.97e-04, below the generic 0.01 BS1 default. |
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD shows zero homozygotes but does not document a healthy adult carrier, age, phenotype, or full early-age penetrance. |
gnomad_v2
gnomad_v4
|
| BS3 | Not met | Not met: K700E increased aberrant splicing and impaired SUGP1 association rather than showing no damaging effect on SF3B1 function. |
PMID:27818134
PMID:31474574
|
| BS4 | Not assessed | Not assessed: no affected family members with documented variant status are available to evaluate lack of segregation. |
|
| BP1 | Not met | Not met: SF3B1 has recurrent disease-associated missense biology, including K700E splicing defects, rather than a primarily truncating disease mechanism. |
PMID:25424858
PMID:27818134
PMID:31474574
|
| BP2 | Not assessed | Not assessed: no phase-resolved observation shows this variant in trans or cis with a pathogenic variant under the BP2 inheritance conditions. |
PMID:27818134
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: REVEL 0.619 exceeds the generic supporting BP4 threshold of 0.29, leaving no benign computational support. |
revel
|
| BP5 | Not assessed | Not assessed: no case is documented with this variant plus an alternate molecular basis for the disease. |
|
| BP6 | Not met | Not met: ClinVar has no exact-variant expert-panel Benign/Likely benign classification, and the available record is conflicting. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.